Leman R B, Kratz J M, Gazes P C
Am Heart J. 1985 Dec;110(6):1242-4. doi: 10.1016/0002-8703(85)90020-1.
We reviewed the need for permanent pacemaker implantation in patients with chronic renal failure who were undergoing dialysis. During a 10-year span, there were seven patients undergoing dialysis in whom a permanent pacemaker was indicated; this was an incidence of 0.68%. During that same period, the general patient population of this hospital had an incidence of permanent pacemaker implantation of about 0.29%. The need for hemodialysis in the same hospital population was 0.51%. Of the seven patients, four had universal pacemakers. Cardiac function was evaluated via radionuclide angiography. Three of the four patients showed improvement with dual-chambered pacing over ventricular pacing. Permanent pacemaker implantation was often needed after initiation of dialysis from 6 to 51 months with a mean of 21 months. During the follow-up period, three patients died from 7 months to 6 years after the institution of permanent pacing; their deaths were secondary to renal disease.
我们回顾了正在接受透析的慢性肾衰竭患者植入永久性起搏器的必要性。在10年期间，有7名接受透析的患者需要植入永久性起搏器，发生率为0.68%。在同一时期，该医院普通患者群体中永久性起搏器植入的发生率约为0.29%。同一医院群体中需要血液透析的比例为0.51%。7名患者中有4名植入了通用型起搏器。通过放射性核素血管造影评估心脏功能。4名患者中有3名在采用双腔起搏而非心室起搏后情况有所改善。在开始透析6至51个月（平均21个月）后，常常需要植入永久性起搏器。在随访期间，3名患者在植入永久性起搏器7个月至6年后死亡，他们的死亡继发于肾脏疾病。
